Several corporate actions are due across Indian listed companies this week and through May 2026, spanning bonus issues, stock splits, rights issues, and an amalgamation. Here is a consolidated tracker of key dates and details investors need to watch.
Bonus issues
Alka India’s bonus issue in the ratio of 6:1 goes ex-date today, May 8, 2026, meaning shareholders on record as of today will be entitled to six additional shares for every one share held. Aptus Pharma has a bonus issue in the ratio of 3:2 with an ex-date of May 12, 2026. Biogen Pharmachem Industries has announced a bonus issue in the ratio of 1:6, with ex-date set for May 15. Dev Labtech Venture has also announced a bonus issue in the 1:1 ratio, also effective May 15.
Stock split
Dev Labtech Venture has simultaneously announced a stock split, reducing its face value from ₹10 per share to ₹5 per share, with the ex-date being May 15, 2026 — the same date as its bonus issue. Investors in Dev Labtech should note that both corporate actions apply on the same ex-date, which will have a combined impact on the share price and share count.
Rights issues open for subscription
Multiple companies currently have rights issues open or opening shortly. Gujarat Cotex closes its rights issue today, May 8, having opened on April 10. EFC (I) had its first tranche ex-date on May 7, with a second rights issue window opening May 13 and closing May 22. Tirupati Innovar opened its rights issue on May 7 with a closing date of May 15. Shakti Press and Innovassynth Technologies (India) both opened on May 7 and May 8 respectively, with both closing on May 18. Panafic Industrials opened its rights issue on April 24 and closes on May 22. Gravity India opened on April 27 with a closing date of May 25. Indrayani Biotech has a rights issue with an extended window, opening May 27 and closing June 25, 2026.
Amalgamation
Gujarat State Petronet has an amalgamation ex-date of May 12, 2026. Shareholders and market participants should monitor exchange circulars for specific terms and swap ratios applicable to the merger transaction.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to consult a registered financial advisor before making any investment decisions. Business Upturn does not hold any position in the securities mentioned.